Adaptimmune Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ADAP and other ETFs, options, and stocks.

About ADAP

Adaptimmune Therapeutics Plc is commercial-stage cell therapy company, which focuses on providing novel cell therapies to people with cancer. Its clinical pipeline includes Afami-cel, Lete-cel, and ADP-A2M4CD8. 

CEO
Adrian Rawcliffe
CEOAdrian Rawcliffe
Employees
506
Employees506
Headquarters
Abingdon, Oxfordshire
HeadquartersAbingdon, Oxfordshire
Founded
2014
Founded2014
Employees
506
Employees506

ADAP Key Statistics

Market cap
72.43M
Market cap72.43M
Price-Earnings ratio
-0.98
Price-Earnings ratio-0.98
Dividend yield
—
Dividend yield—
Average volume
527.31K
Average volume527.31K
High today
$0.2827
High today$0.2827
Low today
$0.262
Low today$0.262
Open price
$0.2675
Open price$0.2675
Volume
562.66K
Volume562.66K
52 Week high
$1.48
52 Week high$1.48
52 Week low
$0.1951
52 Week low$0.1951

Analyst ratings

50%

of 8 ratings
Buy
37.5%
Hold
50%
Sell
12.5%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.